– Targeted metabolomic analysis of serum fatty acids for the prediction of autoimmune diseases. 2019. 
https://www.ncbi.nlm.nih.gov/pubmed/31737644

– Application of Economic Evaluation to Assess Feasibility for Reimbursement of Genomic Testing as Part of Personalized Medicine Interventions. 2019.
https://www.ncbi.nlm.nih.gov/pubmed/31427963
– Estimating the Effectiveness of DPYD Genotyping in Italian Individuals Suffering from Cancer Based on the Cost of Chemotherapy-Induced Toxicity. 2019.
https://www.ncbi.nlm.nih.gov/pubmed/31155283 

– Cost-effectiveness analysis of pharmacogenomics-guided clopidogrel treatment in Spanish patients undergoing percutaneous coronary intervention. 2019
https://www.ncbi.nlm.nih.gov/pubmed/30647444

– Integrating Next-Generation Sequencing in the Clinical Pharmacogenomics Workflow. 2019 
https://www.ncbi.nlm.nih.gov/pubmed/31024324

– Generic Cost-Effectiveness Models: A Proof of Concept of a Tool for Informed Decision-Making for Public Health Precision Medicine. 2018
https://www.ncbi.nlm.nih.gov/pubmed/31189173

– Performance Ratio Based Resource Allocation Decision-Making in Genomic Medicine. 2017 
https://www.ncbi.nlm.nih.gov/pubmed/28118098

– Expanded national database collection and data coverage in the FINDbase worldwide database for clinically relevant genomic variation allele frequencies. 2017
https://www.ncbi.nlm.nih.gov/pubmed/27924022

– Implementing Pharmacogenomics in Europe: Design and Implementation Strategy of the Ubiquitous Pharmacogenomics Consortium. 2017
https://www.ncbi.nlm.nih.gov/pubmed/28027596

– Measuring the value of pharmacogenomics evidence. 2017
https://www.ncbi.nlm.nih.gov/pubmed/28581028

– Advancing Global Precision Medicine: An Overview of Genomic Testing and Counseling Services in Malaysia. 2017 
https://www.ncbi.nlm.nih.gov/pubmed/29173101

 -Genomic Medicine Without Borders: Which Strategies Should Developing Countries Employ to Invest in Precision Medicine? A New “Fast-Second Winner” Strategy. 2017
https://www.ncbi.nlm.nih.gov/pubmed/29140767 

– A European spectrum of pharmacogenomic biomarkers: Implications for clinical pharmacogenomics. 2016 
https://www.ncbi.nlm.nih.gov/pubmed/27636550

– Test pricing and reimbursement in Genomic Medicine: Towards a general strategy. Public Health Genomics. 2016 
https://www.ncbi.nlm.nih.gov/pubmed/27676083

– A brighter future for the implementation of pharmacogenomic testing.  2016
https://www.ncbi.nlm.nih.gov/pubmed/27577544

– Economic analysis of pharmacogenomic-guided clopidogrel treatment in Serbian patients with myocardial infarction undergoing primary percutaneous coronary intervention. 2016 
https://www.ncbi.nlm.nih.gov/pubmed/27767438

– Economic Evaluation of Three Frequently Used Gonadotrophins in Assisted Reproduction Techniques in the Management of Infertility in the Netherlands. 2016
https://www.ncbi.nlm.nih.gov/pubmed/27581117

– An Alternative Methodological Approach for Cost-Effectiveness Analysis and Decision Making in Genomic Medicine. 2016 
https://www.ncbi.nlm.nih.gov/pubmed/27096406

– Economic evaluation of pharmacogenomic-guided warfarin treatment for elderly Croatian atrial fibrillation patients with ischemic stroke. 2015
https://www.ncbi.nlm.nih.gov/pubmed/25616100

– Key challenges for next generation pharmacogenomics.  2014
https://www.ncbi.nlm.nih.gov/pubmed/24723683

– Personalized pharmacogenomics profiling using whole genome sequencing. 2014
https://www.ncbi.nlm.nih.gov/pubmed/25141897

– Economic Evaluation of Pharmacogenomics: A Value-Based Approach to Pragmatic Decision Making in the Face of Complexity. 2014
https://www.ncbi.nlm.nih.gov/pubmed/25278172

– The cost of blood collection in Greece: an economic analysis. 2014
https://www.ncbi.nlm.nih.gov/pubmed/24947494

– The efficiency of the public dental services (PDS) in Cyprus and selected determinants. 2013
https://www.ncbi.nlm.nih.gov/pubmed/24139100

– Coronary artery bypass grafting with minimal versus conventional extracorporeal circulation; an economic analysis. 2013 
https://www.ncbi.nlm.nih.gov/pubmed/23992927

– Relevance of pharmacogenomics for developing countries in Europe: implementation in the Maltese population. 2012
https://www.um.edu.mt/library/oar/handle/123456789/1153

– Locus-specific databases domain and data content analysis: Evolution and content maturation towards clinical use. 2010 
https://www.ncbi.nlm.nih.gov/pubmed/20672379

– Factors influencing prescribing behaviour of physicians in Greece and Cyprus: results from a questionnaire based survey. 2009 
https://www.ncbi.nlm.nih.gov/pubmed/19695079

– Analysis of published economic evaluations of angiotensin receptor blockers. 2009.
https://www.ncbi.nlm.nih.gov/pubmed/19329412

– XELOX versus FOLFOX6 as an adjuvant treatment in colorectal cancer: an economic analysis. 2009.
https://www.ncbi.nlm.nih.gov/pubmed/19215190